Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome
- 1 September 2002
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 108 (3) , 162-163
- https://doi.org/10.1159/000064699
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000Seminars in Thrombosis and Hemostasis, 2000
- The Treatment of Bleeding in Hemophilic Patients with Inhibitors with Recombinant Factor VIIaSeminars in Thrombosis and Hemostasis, 2000
- Recombinant Factor VIIa in the Treatment of Bleeding in Hemophilic Children with InhibitorsSeminars in Thrombosis and Hemostasis, 2000